Dr. Kasper on Imatinib in Recist Progressive Desmoid Tumors

0 Views
administrator
administrator
07/04/23

Bernd Kasper, MD, PhD, professor, Universitätsmedizin Mannheim, Mannheim, discusses results of a phase II study exploring the efficacy of imatinib (Gleevac) in patients with racist progressive desmoid tumors.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next